LHLing Hao

Ling Hao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ling Hao has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Hui Ling Chen

    Department of Laboratory Medicine, Guangzhou First People’s Hospital, School of Medicine, South China University of Technology, Guangzhou 510180, China

    2 shared publications
  • Nadeem Ullah

    Department of Clinical Microbiology, Umeå University, Umeå, Sweden

    2 shared publications
  • Shuquan Wei

    Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital, School of Medicine, South China University of Technology, China

    2 shared publications
  • Xiao Yang

    Department of Laboratory Medicine, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, PR China

    2 shared publications
  • Xiao Yang

    Department of Laboratory Medicine, Guangzhou First People’s Hospital, School of Medicine, South China University of Technology, Guangzhou 510180, China

    2 shared publications
  • Ziwen Zhao

    The First Affiliated Hospital of Jinan University, Guangzhou, China

    2 shared publications

Latest Publications

  • Open Access

    Molecular and metabolic features of colistin-resistant ST11 carbapenem-resistant Klebsiella pneumoniae

    by Ling Hao, Xiao Yang, Nadeem Ullah

    Introduction. The emergence of colistin-resistant carbapenem-resistant Klebsiella pneumoniae (CRKP) poses a critical threat to public health, a challenge that was exacerbated by the coronavirus disease 2019 (COVID-19) pandemic. Gap statement. The specific metabolic adaptations that underlie colistin resistance in high-risk sequence type 11 (ST11) CRKP clinical strains, particularly in direct comparison with their susceptible counterparts, remain poorly characterized. Aim. To explore metabolic features associated with colistin resistance in clinical CRKP isolates. Methodology. Twelve CRKP strains, encompassing both colistin-resistant and colistin-susceptible isolates, were analysed for antimicrobial resistance profiles, virulence-associated genes, sequence types and biofilm formation capacity. Comparative untargeted metabolomics was performed to map metabolic shifts between the resistant and susceptible groups. Results. All isolates belonged to the high-risk clone ST11, harboured the KPC-2 carbapenemase and carried multiple virulence genes, with K2 being the dominant serotype. All isolates formed biofilms, with resistant isolates showing enhanced capacity. Colistin resistance was chromosomally mediated by pmrB and mgrB mutations, with no plasmid-encoded mcr genes detected. Untargeted metabolomics identified 126 significantly differentially expressed metabolites (DEMs) between resistant and susceptible isolates. These DEMs were significantly enriched in lipids and lipid-like molecules. Colistin-resistant strains exhibited increased glycerophospholipids, sphingolipids and fatty acids, coupled with decreased metabolites from central carbon and amino acid pathways. Conclusion. In this exploratory study, colistin resistance in these ST11 CRKP strains was associated with chromosomal alterations in pmrB and mgrB and with marked shifts in membrane-associated lipid metabolites. While these metabolic changes suggested membrane remodelling, they remain associative and require functional validation. Beyond resistance, the co-carriage of these traits with robust virulence gene expression highlights a critical clinical challenge, supporting the need for further research into combination therapies targeting these adaptive lipid pathways.

  • Open Access

    Integrated Proteomics and Metabolomics Reveal Multifaceted Mechanisms of Colistin Resistance in Acinetobacter baumannii

    by Ling Hao, Xiao Yang, Nadeem Ullah, Yujun Li, Shuquan Wei, Qizhi Wang, Zhuxiang Zhao, Zhike Liang

    Background: The emergence of colistin-resistant Acinetobacter baumannii, particularly extensively drug-resistant carbapenemresistant A. baumannii (XDR-CRAB), poses a critical global health threat; however, the molecular mechanisms underlying this resistance remain poorly characterized. Methods: This study utilized integrated tandem mass tag (TMT)-based proteomics and untargeted metabolomics to compare a representative drug-sensitive (DS) strain, a colistin-sensitive multidrug-resistant (MDR-CRAB) strain, and a colistin-resistant extensively drug-resistant (XDR-CRAB) isolate from a Guangzhou hospital, China, with a primary focus on the molecular features associated with resistance in the XDR isolate. Results: Proteomic analysis identified 260 differentially expressed proteins (DEPs) across these strains, with 98 strongly linked to the colistin-resistant phenotype. These DEPs were enriched in functions related to polysaccharide and sulfate transport, aromatic compound degradation, and cationic antimicrobial peptide (CAMP) resistance. Upregulation of the lipid A modification system, driven by increased expression of PmrA (4.2-fold), PmrB (2.9-fold), and PmrC (5.5-fold) in the XDR strain compared to the MDR strain, is consistent with this CAMP resistance. Metabolomic analysis identified 747 metabolites, with lipids and lipid-like molecules being the most altered class. The XDR strain exhibited reduced relative abundance of several glycerophospholipids and fatty acids/ conjugates, when compared to the MDR strain, indicating cell membrane remodeling. Pathway enrichment analysis further implicated purine, glycerophospholipid, starch/sucrose, and glutathione metabolism in colistin resistance. Conclusion: Colistin resistance in A. baumannii appears to involve a multifaceted strategy integrating lipid A modification, cell membrane remodeling, and metabolic reprogramming. This study provides a high-resolution molecular blueprint of colistin resistant A. baumannii and generates testable hypotheses to inform future diagnostic and therapeutic strategies against resistant infections.


  • Open Access

    CD39 dynamics in tuberculosis: a potential biomarker of immune dysregulation and T cell exhaustion

    by Ling Hao, Qari Muhammad Imran, Nadeem Ullah

    Background: Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a global health crisis complicated by immune dysregulation and T cell exhaustion. CD39, an ectonucleotidase generating immunosuppressive adenosine, is implicated in cancer and chronic infections, yet its spatiotemporal role in TB pathogenesis remains unclear.Methods: Multiple publicly available datasets were utilized to evaluate CD39 across TB disease stages, diverse infectious diseases and anti-TB treatment. Diagnostic accuracy was evaluated via ROC curves and combined signature analysis. Immune cell infiltration were analyzed using CIBERSORTx. Cytokine profiles and age-stratified associations were examined. Pathway enrichment analysis was performed by GSEA. Single-cell analysis of non-human primate granulomas assessed CD39’s temporal dynamics, utilizing Monocle 3 for CD39+ T-cell trajectory analysis.Results: CD39 was upregulated in active TB patients versus TB infection (TBI) and healthy controls (HC), correlating with older age, disease severity, and distinct expression patterns compared to other respiratory and systemic infections. CD39 demonstrated superior diagnostic accuracy over IFN-γ in distinguishing TB from TBI/HC and other respiratory diseases. Combining CD39 with TBX21 or GZMB further improved diagnostic specificity. High CD39 expression correlated with suppressed Th1 and elevated Th2/Th17/regulatory cytokines, alongside pronounced neutrophil infiltration. Age-stratified analysis revealed complex age-dependent associations of CD39 expression with various immune cell types. Single-cell analysis revealed declining CD39 transcriptional activity during prolonged infection despite expanded cellular distribution, linked to early T cell maturation followed by broader immunomodulatory shifts. Decreased CD39 expression with anti-TB treatment correlated with improved immune cell balance and resolved T cell exhaustion.Conclusion: CD39 is a critical regulator of immune exhaustion and neutrophil-driven inflammation in TB, with diagnostic and therapeutic potential. Targeting CD39 may provide a novel therapeutic strategy for TB.


  • Open Access

    Distribution and Drug Resistance of Bacterial Infection in Hospitalized Patients at the Respiratory Department before and after the COVID-19 Pandemic in Guangzhou, China

    by Ling Hao, Xiao Yang, Huiling Chen, Shuquan Wei, Banglao Xu, Ziwen Zhao

    Since COVID-19 might have a lasting impact on global public health, it is crucial to analyze its effect on drug-resistant bacterial infections in the respiratory system for the prevention and control of hospital infections. This work aimed to investigate the impact of the COVID-19 outbreak on the clinical distribution and antibiotic resistance of bacterial infection among hospitalized patients in the respiratory unit in order to establish strategies to control antibiotic-resistant infections. Electronic clinical data registry records from 2018 to 2022 were retrospectively analyzed. A total of 36,829 clinical specimens, including sputum, bronchoalveolar lavage fluid, blood, and urine, were collected from 16,073 patients admitted to the Guangzhou First People’s Hospital from January 2018 to December 2022. Among them, 2209 samples were culture-positive. The bacterial isolation rates of different types of samples showed a similar trend from 2019 to 2022, with an increase in 2020 and 2022 and a decrease in 2021. Different bacterial species were separated from different types of samples. The most reported pathogens were identified in sputum samples. Gram-positive isolates were prevalent in urine samples, while Gram-negative bacilli were the predominant pathogenic bacteria isolated from respiratory tract and blood samples. Pseudomonas aeruginosa (P. aeruginosa), Acinetobacter baumannii (A. baumannii) complex, and Klebsiella pneumoniae (K. pneumoniae) were the most abundant Gram-negative bacteria in sputum samples, of which A. baumannii complex had the highest resistance to all tested antibiotics except colistin. Notably, there has been a substantial prevalence of carbapenem-resistant P. aeruginosa, A. baumannii, and K. pneumoniae in the past five years. This alarming situation calls for greater attention and precaution with prescribed antibiotics to limit the generation and spread of new multidrug-resistant bacteria and improve therapeutic management.


  • Open Access

    Molecular Characteristics and Quantitative Proteomic Analysis of Klebsiella pneumoniae Strains with Carbapenem and Colistin Resistance

    by Ling Hao, Xiao Yang, Huiling Chen, Zexun Mo, Yujun Li, Shuquan Wei, Ziwen Zhao

    Carbapenem-resistant Klebsiella pneumoniae (CRKP) are usually multidrug resistant (MDR) and cause serious therapeutic problems. Colistin is a critical last-resort therapeutic option for MDR bacterial infections. However, increasing colistin use has led to the emergence of extensively drug-resistant (XDR) strains, raising a significant challenge for healthcare. In order to gain insight into the antibiotic resistance mechanisms of CRKP and identify potential drug targets, we compared the molecular characteristics and the proteomes among drug-sensitive (DS), MDR, and XDR K. pneumoniae strains. All drug-resistant isolates belonged to ST11, harboring blaKPC and hypervirulent genes. None of the plasmid-encoded mcr genes were detected in the colistin-resistant XDR strains. Through a tandem mass tag (TMT)-labeled proteomic technique, a total of 3531 proteins were identified in the current study. Compared to the DS strains, there were 247 differentially expressed proteins (DEPs) in the MDR strains and 346 DEPs in the XDR strains, respectively. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis revealed that a majority of the DEPs were involved in various metabolic pathways, which were beneficial to the evolution of drug resistance in K. pneumoniae. In addition, a total of 67 DEPs were identified between the MDR and XDR strains. KEGG enrichment and protein–protein interaction network analysis showed their participation in cationic antimicrobial peptide resistance and two-component systems. In conclusion, our results highlight the emergence of colistin-resistant and hypervirulent CRKP, which is a noticeable superbug. The DEPs identified in our study are of great significance for the exploration of effective control strategies against infections of CRKP.